X4 PHARMACEUTICALS, INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $22.5M | $81.3M | $26.7M |
| FY2018 | $21.6M | $9.9M | $8.1M |
| FY2019 | $31.5M | $160.7M | $126.2M |
| FY2020 | $50.1M | $122.9M | $78.7M |
| FY2021 | $52.8M | $117.2M | $81.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $22.5M | $81.3M | $26.7M |
| FY2018 | $21.6M | $9.9M | $8.1M |
| FY2019 | $31.5M | $160.7M | $126.2M |
| FY2020 | $50.1M | $122.9M | $78.7M |
| FY2021 | $52.8M | $117.2M | $81.8M |